Organization
University of Southern California
71 clinical trials
Clinical trial
SIMPLE Study: A Prospective and Randomized Trial of a Simplified Immunosuppressive Protocol Utilizing Low Dose EnvarsusXRStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase IIa Trial of sEphB4-HSA in Combination With Anti PD-1 Antibody (Pembrolizumab, MK3475) in Patients With Non-small Cell Lung and Head/Neck CancerStatus: Active (not recruiting), Estimated PCD: 2025-03-10
Clinical trial
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney DiseaseStatus: , Estimated PCD: 2025-12-31
Clinical trial
A Phase Ib Study of Botensilimab Plus Balstilimab and Fasting-Mimicking Diet (FMD) Plus Vitamin C in Patients With KRAS-Mutant Metastatic Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
Characterizing Breast Masses Using an Integrative Framework of Machine Learning and RadiomicsStatus: Recruiting, Estimated PCD: 2024-11-05
Clinical trial
Phase 1B/II Study of Escalating Doses of Pevonedistat (TAK-924, Formerly MLN4924) Administered in Combination With Standard Induction Chemotherapy (Cytarabine and Idarubicin) in Newly Diagnosed High Risk Acute Myelogenous Leukemia (AML)Status: Active (not recruiting), Estimated PCD: 2024-10-13
Clinical trial
Prospective Study of Induction Medications Used in the Rapid Sequence Intubation of Trauma Patients and a Comparison of Effects on OutcomesStatus: Not yet recruiting, Estimated PCD: 2028-04-30
Clinical trial
A Phase I Study of In Situ Immunomodulation With CDX-301, Radiotherapy, CDX-1140, and Poly-ICLC in Patients With Unresectable and Metastatic Solid Tumors With Injectable Palpable DiseaseStatus: Recruiting, Estimated PCD: 2025-01-09
Clinical trial
A Phase II Trial of sEphB4-HSA in Combination With Anti PD1 Antibody Pembrolizumab (MK-3475) for Solid TumorsStatus: Recruiting, Estimated PCD: 2025-11-21
Clinical trial
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early SyphilisStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Area B: Precise DCE-MRI Assessment of Brain TumorsStatus: Terminated, Estimated PCD: 2023-11-22
Clinical trial
Supplements for Controlling Resistance to InsulinStatus: Terminated, Estimated PCD: 2008-08-01
Clinical trial
Long-Term Nicotine Treatment of Mild Cognitive ImpairmentStatus: Active (not recruiting), Estimated PCD: 2025-08-01
Clinical trial
First in Human Dose Escalation Study of AU409 in Patients With Advanced Primary Liver Cancers or Advanced Solid Tumor With Liver Predominant Metastatic DiseaseStatus: Recruiting, Estimated PCD: 2026-03-29
Clinical trial
Novel Dynamic PET Kinetics and MRI Radiomics Analyses in Brain TumorsStatus: Completed, Estimated PCD: 2023-09-18
Clinical trial
Ability of Oral Steroid (Oxandrolone) to Halt Fatty Infiltration and Aid Rotator Cuff Healing: A Double-Blind, Randomized Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)Status: Recruiting, Estimated PCD: 2025-11-03
Clinical trial
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN StudyStatus: Completed, Estimated PCD: 2023-09-29
Clinical trial
A Pilot Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-assisted Psychedelic TherapyStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Atherosclerosis Intervention With Novel Tissue Selective Estrogen Complex TherapyStatus: Recruiting, Estimated PCD: 2026-10-31
Clinical trial
Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/IvacaftorStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Short-Term Fasting Prior to Standard Checkpoint Blockade Using PD-1/PD-L1 Inhibition: A Pilot Safety and Feasibility StudyStatus: Recruiting, Estimated PCD: 2024-08-12
Clinical trial
Real-Time Contrast Enhanced Ultrasound and Ultrasound-Based Elastography: Novel Quantitative Imaging Techniques for Early Therapy Response Assessment in SarcomasStatus: Completed, Estimated PCD: 2024-01-19
Clinical trial
Epigenetic Regulation of Stress-related Genes in Relation to MDMA-Assisted Psychotherapy Treatment for Post-Traumatic Stress DisorderStatus: Active (not recruiting), Estimated PCD: 2023-11-01
Clinical trial
Effects of Acute Nicotine Administration on Motivational MechanismsStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder SurgeryStatus: Completed, Estimated PCD: 2023-01-11
Clinical trial
Pilot Study of Linezolid for Early Syphilis TreatmentStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Split-Face Study Comparing OnabotulinumtoxinA (Botox) and PrabotulinumtoxinA (Jeuveau) in Treating Glabellar LinesStatus: Active (not recruiting), Estimated PCD: 2025-05-01
Clinical trial
Trazodone vs. Quetiapine for the Treatment of ICU Delirium: A Prospective Observational Pilot StudyStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase I/II Study of Regorafenib and Pembrolizumab in Metastatic Colorectal Cancer Patients in 3rd and 4th Line SettingStatus: Active (not recruiting), Estimated PCD: 2024-06-21
Clinical trial
Evaluating the Safety and Efficacy of Different Routes of Neostigmine Administration for Acute Colonic Pseudo Obstruction: a Prospective Randomized TrialStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase 1b/2 Study of Standard Doses of Bortezomib and Pembrolizumab ± Reovirus (Pelareorep) Combination Therapy in Patients With Relapsed Multiple Myeloma (AMBUSH Study)Status: Recruiting, Estimated PCD: 2025-10-07
Clinical trial
A Phase I Study of FID-007 in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-05-25
Clinical trial
Risk Stratification Using Genetic Markers of Patients With a History of Pulmonary Embolism Post Total Hip or Total Knee ArthroplastyStatus: , Estimated PCD: 2026-04-23
Clinical trial
Immune Activation and Cellular Response From Enzalutamide Alone or With Radium223 in Men With Metastatic, Castration-Resistant Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2024-11-21
Clinical trial
A Randomized Controlled Pilot Trial of Cyclosporine vs Steroids in DRESSStatus: , Estimated PCD: 2025-04-30
Clinical trial
A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-02
Clinical trial
Pilot Feasibility Study of 18F-FMAU PET for Diagnosing and Characterizing Prostate CancerStatus: Terminated, Estimated PCD: 2021-07-21
Clinical trial
Comparison of Trazodone vs Quetiapine vs Placebo for the Treatment of ICU Delirium: A Randomized Controlled Trial (The TraQ Study)Status: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based RegimenStatus: Terminated, Estimated PCD: 2021-03-02
Clinical trial
Effects of Cured Bond On Sealant Retention In The Pediatric PopulationStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Mechanisms Linking Obsessive-Compulsive Symptoms and Tobacco DependenceStatus: Completed, Estimated PCD: 2023-03-23
Clinical trial
A Two-Cohort Randomized Phase 2 Trial of the IRX-2 Regimen in Women With Squamous Cervical Intraepithelial Neoplasia 3 (CIN 3) or Vulvar Intraepithelial Neoplasia 3 (VIN 3)Status: Active (not recruiting), Estimated PCD: 2024-11-08
Clinical trial
Double-Blinded Randomized Controlled Study Investigating the Efficacy of Exparel (Liposomal Bupivacaine) for Postoperative Pain Relief in Mandibular Third Molar ExtractionsStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
Effects of e-Cigarettes on Perceptions and Behavior - Substudy 1Status: Completed, Estimated PCD: 2020-03-01
Clinical trial
A Phase 1b Study of REOLYSIN® (Reovirus Serotype 3 - Dearing Strain) Combined With Standard Doses of Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaStatus: Completed, Estimated PCD: 2022-04-19
Clinical trial
Life's End Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Delivery of Essential Fatty Acids to the BrainStatus: Completed, Estimated PCD: 2024-05-16
Clinical trial
A Phase I/II Multicenter Study Combining Guadecitabine, a DNA Methyltransferase Inhibitor, With Atezolizumab, an Immune Checkpoint Inhibitor, in Patients With Intermediate or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
A Phase 2, Double-blind, Randomized Study to Compare the Effect of Curcumin Versus Placebo on Inflammatory Cytokines, Symptoms and Disease Parameters in Clonal Cytopenia of Undetermined Significance (CCUS), Low-Risk Myelodysplastic Syndrome (LR-MDS), and Myeloproliferative Neoplasms (MPNs)Status: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Phase II Study of Subcutaneous Atezolizumab in NSCLC Patients Using a Decentralized Clinical Trial ModelStatus: Recruiting, Estimated PCD: 2025-12-07
Clinical trial
A First-in-Human Phase I Study of Intravesical sEphB4-HSA in Patients With "BCG-Unresponsive" Bladder Carcinoma In Situ (CIS), Completely Resected High Grade Ta/T1, to Establish the Maximum Tolerated Dose (MTD) or Recommended Phase II Dose (RP2D)Status: Withdrawn, Estimated PCD: 2024-08-01
Clinical trial
A Phase 2 Single-arm, Open Label Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Ketamine HCl Prolonged Release Tablets in Participants With Complex Regional Pain SyndromeStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
Evaluating the PD-1 Checkpoint Inhibitor, Cemiplimab, as Neoadjuvant Therapy in High Risk Localized, Locally Recurrent, and Regionally Advanced Cutaneous Squamous Cell Carcinoma: A Phase II Pilot StudyStatus: Recruiting, Estimated PCD: 2024-06-17
Clinical trial
High Dose Bupropion Treatment for Smoking Cessation - Pilot StudyStatus: Terminated, Estimated PCD: 2023-07-01
Clinical trial
A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid TumorsStatus: Terminated, Estimated PCD: 2019-05-29
Clinical trial
Phase II Randomized Double Blind Trial of PF-04518600, an OX40 Antibody, in Combination With Axitinib Versus Axitinib in Immune-Checkpoint Inhibitor Exposed Patients With Metastatic Renal Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2024-07-19
Clinical trial
A Phase II Single Center Single Arm Pilot Study Administering Danazol for Treatment of Cytopenias in Patients With CirrhosisStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Phase Ib Clinical Trial of Autologous Anti-NY-ESO-1 TCR-Engineered T Cells in Patients With Relapsed/Refractory Locally Advanced or Metastatic NY-ESO-1-Expressing Triple Negative Breast CancerStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Clinical trial
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control TrialStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Window of Opportunity Study of Taxanes in Head and Neck CancerStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Use of 2% Chlorhexidine (CHX) as Intracanal Medicament in Endodontic Emergencies and to Compare Its Use and Effectiveness With CaOH2 (CH) Calcium Hydroxide PasteStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Minocycline as a Neuroprotective Agent Against Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageStatus: Active (not recruiting), Estimated PCD: 2027-12-31
Clinical trial
Safety and Efficacy of Allograft Adipose Matrix Injectable for Glottal InsufficiencyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Empiric Treatment for Suspected Acute HIV Infection in the Emergency DepartmentStatus: Active (not recruiting), Estimated PCD: 2023-06-01
Clinical trial
Randomized Trial of Short Antibiotic Course to Decrease Post ERCP CholangitisStatus: Recruiting, Estimated PCD: 2024-02-23
Clinical trial
The Seena Magowitz Phase IB/II Trial of CMP-001 (a TLR9 Agonist) in Combination With INCAGN01949 (an Activating Anti-OX40 Antibody) for In Situ Intratumoral Injection for Patients With Stage IV Pancreatic and Other Cancers Except MelanomaStatus: Terminated, Estimated PCD: 2022-12-19
Clinical trial
Mindfulness Training Plus Oxytocin to Reduce Smoking and Craving Among Smokers in WithdrawalStatus: Terminated, Estimated PCD: 2023-12-31
Clinical trial
Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant PopulationsStatus: Completed, Estimated PCD: 2023-07-30